BOVILIS® VL5 SQ
Shown to be effective for the vaccination of healthy cattle against L. canicola, L. grippotyphosa, L. hardjo including L. borgpetersenii serovar hardjo bovis, L. icterohaemorrhagiae, and L. pomona and reproductive disease caused by Campylobacter fetus. Effective against urinary shedding of hardjo bovis organisms.
The bacterin product contains inactivated cultures of Campylobacter fetus and Leptospira canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae, and L. pomona with a proprietary adjuvant.
For use in the vaccination of healthy cattle as an aid in reducing infertility (reproductive disease caused by Campylobacter fetus) and as an aid in preventing leptospirosis (caused by Leptospira canicola, L. grippotyphosa, L. hardjo – including the L. borgpetersenii serovar hardjo bovis, L. icterohaemorrhagiae, and L. pomona) and as an aid in prevention of urinary shedding of L. hardjo organisms.
Mixing & Use Directions
Shake vial well and inject 2.0 mL subcutaneously 14 to 60 days prior to breeding. If packaged with BOVILIS® VISTA® 5 SQ, refer to carton for complete directions. Annual revaccination is recommended.
Store refrigerated at 35°-45°F (2°-7°C). Do not freeze. Use immediately after opening; do not save partial contents. Burn the container and all unused product. Use only in healthy cattle. Do not vaccinate within 21 days before slaughter. If allergic reaction occurs, treat with epinephrine. Contains thimerosal as preservative.
FOR USE IN ANIMALS ONLY
|50 Dose||100 mL||90285003|
NAC No.: 10474460
For additional information, please see the product label.